HEADER TRANSCRIPTION RECEPTOR/COACTIVATOR 21-FEB-02 1L2I TITLE HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH TITLE 2 (R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL AND A TITLE 3 GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN (RESIDUES 297-554); COMPND 5 SYNONYM: ER-ALPHA, OESTROGEN RECEPTOR ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: GLUCOCORTICOID RECEPTOR-INTERACTING PROTEIN 1; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: NR BOX II (RESIDUES 686-698); COMPND 11 SYNONYM: NUCLEAR RECEPTOR COACTIVATOR 2, GRIP1; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET23D; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THIS SEQUENCE SOURCE 13 OCCURS NATURALLY IN MICE. KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ESTROGEN, AGONIST, KEYWDS 2 COACTIVATOR, TRANSCRIPTION RECEPTOR-COACTIVATOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.K.SHIAU,D.BARSTAD,J.T.RADEK,M.J.MEYERS,K.W.NETTLES, AUTHOR 2 B.S.KATZENELLENBOGEN,J.A.KATZENELLENBOGEN,D.A.AGARD,G.L.GREENE REVDAT 4 16-AUG-23 1L2I 1 REMARK SEQADV REVDAT 3 24-JUL-19 1L2I 1 REMARK LINK REVDAT 2 24-FEB-09 1L2I 1 VERSN REVDAT 1 01-MAY-02 1L2I 0 JRNL AUTH A.K.SHIAU,D.BARSTAD,J.T.RADEK,M.J.MEYERS,K.W.NETTLES, JRNL AUTH 2 B.S.KATZENELLENBOGEN,J.A.KATZENELLENBOGEN,D.A.AGARD, JRNL AUTH 3 G.L.GREENE JRNL TITL STRUCTURAL CHARACTERIZATION OF A SUBTYPE-SELECTIVE LIGAND JRNL TITL 2 REVEALS A NOVEL MODE OF ESTROGEN RECEPTOR ANTAGONISM. JRNL REF NAT.STRUCT.BIOL. V. 9 359 2002 JRNL REFN ISSN 1072-8368 JRNL PMID 11953755 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.K.SHIAU,D.BARSTAD,P.M.LORIA,L.CHENG,P.J.KUSHNER,D.A.AGARD, REMARK 1 AUTH 2 G.L.GREENE REMARK 1 TITL THE STRUCTURAL BASIS OF ESTROGEN RECEPTOR/COACTIVATOR REMARK 1 TITL 2 RECOGNITION AND THE ANTAGONISM OF THIS INTERACTION BY REMARK 1 TITL 3 TAMOXIFEN REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 95 927 1998 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/S0092-8674(00)81717-1 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.J.MEYERS,J.SUN,K.E.CARLSON,B.S.KATZENELLENBOGEN, REMARK 1 AUTH 2 J.A.KATZENELLENBOGEN REMARK 1 TITL ESTROGEN RECEPTOR SUBTYPE-SELECTIVE LIGANDS: ASYMMETRIC REMARK 1 TITL 2 SYNTHESIS AND BIOLOGICAL EVALUATION OF CIS- AND REMARK 1 TITL 3 TRANS-5,11-DIALKYL-5,6,11,12-TETRAHYDROCHRYSENES REMARK 1 REF J.MED.CHEM. V. 42 2456 1999 REMARK 1 REFN ISSN 0022-2623 REMARK 1 DOI 10.1021/JM990101B REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 34533 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.500 REMARK 3 FREE R VALUE TEST SET COUNT : 2304 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2986 REMARK 3 BIN R VALUE (WORKING SET) : 0.2964 REMARK 3 BIN FREE R VALUE : 0.3359 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 201 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3782 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 166 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.16400 REMARK 3 B22 (A**2) : 0.13800 REMARK 3 B33 (A**2) : 6.02600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.13500 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.080 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 17.99 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.720 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.975 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.925 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.378 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.223 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 61.93 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1L2I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-02. REMARK 100 THE DEPOSITION ID IS D_1000015582. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 103 REMARK 200 PH : 8.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.10 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34533 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 46.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06500 REMARK 200 FOR THE DATA SET : 18.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.53100 REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 3ERD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% (W/V) PEG 4000, 50 MM MAGNESIUM REMARK 280 CHLORIDE, 53 MM TRIS PH 8.8 292-294 K, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.30000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 21.66699 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -54.92052 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 294 REMARK 465 ASP A 295 REMARK 465 PRO A 296 REMARK 465 MET A 297 REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 THR A 460 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 ARG A 548 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 MET B 294 REMARK 465 ASP B 295 REMARK 465 PRO B 296 REMARK 465 MET B 297 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 GLU B 471 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 LYS C 686 REMARK 465 SER C 697 REMARK 465 SER C 698 REMARK 465 ASP D 696 REMARK 465 SER D 697 REMARK 465 SER D 698 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 306 CG CD1 CD2 REMARK 470 SER A 309 OG REMARK 470 GLU A 330 CG CD OE1 OE2 REMARK 470 ASP A 332 CG OD1 OD2 REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 397 CG CD OE1 OE2 REMARK 470 LYS A 401 CG CD CE NZ REMARK 470 ASP A 411 CG OD1 OD2 REMARK 470 CCS A 417 CD CE OZ1 OZ2 REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 GLU A 423 CG CD OE1 OE2 REMARK 470 MET A 437 CG SD CE REMARK 470 TYR A 459 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LEU A 469 CG CD1 CD2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 ASP A 473 CG OD1 OD2 REMARK 470 ARG A 477 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 484 CG OD1 OD2 REMARK 470 TYR A 526 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 ASN A 532 CG OD1 ND2 REMARK 470 LEU A 536 CG CD1 CD2 REMARK 470 ASP A 538 CG OD1 OD2 REMARK 470 ASP B 332 CG OD1 OD2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 ASP B 473 CG OD1 OD2 REMARK 470 LYS B 531 CG CD CE NZ REMARK 470 HIS C 687 CG ND1 CD2 CE1 NE2 REMARK 470 LYS C 688 CG CD CE NZ REMARK 470 LYS D 686 CG CD CE NZ REMARK 470 LYS D 688 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 332 56.25 38.21 REMARK 500 ASP B 332 115.35 174.66 REMARK 500 HIS B 398 70.06 -118.76 REMARK 500 VAL B 534 143.40 -174.85 REMARK 500 LYS C 688 -70.02 -103.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETC A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETC B 800 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ERD RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING REMARK 900 PROTEIN 1 NR BOX II PEPTIDE REMARK 900 RELATED ID: 1L2J RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 (R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL DBREF 1L2I A 297 554 UNP P03372 ESR1_HUMAN 297 554 DBREF 1L2I B 297 554 UNP P03372 ESR1_HUMAN 297 554 DBREF 1L2I C 686 698 UNP Q61026 NCOA2_MOUSE 686 698 DBREF 1L2I D 686 698 UNP Q61026 NCOA2_MOUSE 686 698 SEQADV 1L2I MET A 294 UNP P03372 CLONING ARTIFACT SEQADV 1L2I ASP A 295 UNP P03372 CLONING ARTIFACT SEQADV 1L2I PRO A 296 UNP P03372 CLONING ARTIFACT SEQADV 1L2I CCS A 417 UNP P03372 CYS 417 MODIFIED RESIDUE SEQADV 1L2I MET B 294 UNP P03372 CLONING ARTIFACT SEQADV 1L2I ASP B 295 UNP P03372 CLONING ARTIFACT SEQADV 1L2I PRO B 296 UNP P03372 CLONING ARTIFACT SEQADV 1L2I CCS B 417 UNP P03372 CYS 417 MODIFIED RESIDUE SEQRES 1 A 261 MET ASP PRO MET ILE LYS ARG SER LYS LYS ASN SER LEU SEQRES 2 A 261 ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU SEQRES 3 A 261 LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP SEQRES 4 A 261 PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU SEQRES 5 A 261 LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE SEQRES 6 A 261 ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR SEQRES 7 A 261 LEU HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU SEQRES 8 A 261 GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU SEQRES 9 A 261 HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU SEQRES 10 A 261 ASP ARG ASN GLN GLY LYS CCS VAL GLU GLY MET VAL GLU SEQRES 11 A 261 ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG SEQRES 12 A 261 MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SEQRES 13 A 261 SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SEQRES 14 A 261 SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE SEQRES 15 A 261 HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS SEQRES 16 A 261 LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS SEQRES 17 A 261 GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE SEQRES 18 A 261 ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER SEQRES 19 A 261 MET LYS CYS LYS ASN VAL VAL PRO LEU TYR ASP LEU LEU SEQRES 20 A 261 LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SEQRES 21 A 261 SER SEQRES 1 B 261 MET ASP PRO MET ILE LYS ARG SER LYS LYS ASN SER LEU SEQRES 2 B 261 ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU SEQRES 3 B 261 LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP SEQRES 4 B 261 PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU SEQRES 5 B 261 LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE SEQRES 6 B 261 ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR SEQRES 7 B 261 LEU HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU SEQRES 8 B 261 GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU SEQRES 9 B 261 HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU SEQRES 10 B 261 ASP ARG ASN GLN GLY LYS CCS VAL GLU GLY MET VAL GLU SEQRES 11 B 261 ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG SEQRES 12 B 261 MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SEQRES 13 B 261 SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SEQRES 14 B 261 SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE SEQRES 15 B 261 HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS SEQRES 16 B 261 LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS SEQRES 17 B 261 GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE SEQRES 18 B 261 ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER SEQRES 19 B 261 MET LYS CYS LYS ASN VAL VAL PRO LEU TYR ASP LEU LEU SEQRES 20 B 261 LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SEQRES 21 B 261 SER SEQRES 1 C 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER SEQRES 1 D 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER MODRES 1L2I CCS A 417 CYS CARBOXYMETHYLATED CYSTEINE MODRES 1L2I CCS B 417 CYS CARBOXYMETHYLATED CYSTEINE HET CCS A 417 6 HET CCS B 417 10 HET CL A 601 1 HET ETC A 600 24 HET ETC B 800 24 HETNAM CCS CARBOXYMETHYLATED CYSTEINE HETNAM CL CHLORIDE ION HETNAM ETC (R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2, HETNAM 2 ETC 8-DIOL FORMUL 1 CCS 2(C5 H9 N O4 S) FORMUL 5 CL CL 1- FORMUL 6 ETC 2(C22 H24 O2) FORMUL 8 HOH *166(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 ALA A 322 1 12 HELIX 3 3 SER A 338 LYS A 362 1 25 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ASN A 413 VAL A 418 5 6 HELIX 7 7 GLY A 420 ASN A 439 1 20 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 LEU A 469 ALA A 493 1 25 HELIX 10 10 THR A 496 LYS A 531 1 36 HELIX 11 11 TYR A 537 ALA A 546 1 10 HELIX 12 12 LEU B 306 LEU B 310 5 5 HELIX 13 13 THR B 311 GLU B 323 1 13 HELIX 14 14 SER B 338 ARG B 363 1 26 HELIX 15 15 THR B 371 SER B 395 1 25 HELIX 16 16 ASN B 413 VAL B 418 5 6 HELIX 17 17 GLY B 420 ASN B 439 1 20 HELIX 18 18 GLN B 441 SER B 456 1 16 HELIX 19 19 LYS B 472 ALA B 493 1 22 HELIX 20 20 THR B 496 LYS B 531 1 36 HELIX 21 21 TYR B 537 ALA B 546 1 10 HELIX 22 22 LYS C 688 ASP C 696 1 9 HELIX 23 23 LYS D 688 GLN D 695 1 8 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C LYS A 416 N CCS A 417 1555 1555 1.33 LINK C CCS A 417 N VAL A 418 1555 1555 1.33 LINK C LYS B 416 N CCS B 417 1555 1555 1.33 LINK C CCS B 417 N VAL B 418 1555 1555 1.33 CISPEP 1 ARG A 335 PRO A 336 0 -0.10 CISPEP 2 ARG B 335 PRO B 336 0 -0.02 SITE 1 AC1 4 HOH A 2 ARG A 352 HOH B 39 ARG B 352 SITE 1 AC2 9 HOH A 10 LEU A 346 THR A 347 GLU A 353 SITE 2 AC2 9 ARG A 394 PHE A 404 GLY A 521 HIS A 524 SITE 3 AC2 9 LEU A 525 SITE 1 AC3 13 HOH B 48 LEU B 346 THR B 347 GLU B 353 SITE 2 AC3 13 LEU B 387 MET B 388 ARG B 394 PHE B 404 SITE 3 AC3 13 ILE B 424 LEU B 428 GLY B 521 HIS B 524 SITE 4 AC3 13 LEU B 525 CRYST1 54.545 82.600 59.040 90.00 111.53 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018333 0.000000 0.007233 0.00000 SCALE2 0.000000 0.012107 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018208 0.00000